AdvaMed04.15.20
Several prominent medical technology company executives have been named to the White House task force designated by President Trump to provide recommendations on how best to safely reopen the U.S. economy in the wake of the coronavirus (COVID-19) pandemic.
“The inclusion of so many medtech community leaders on this key White House task force speaks to the important role our industry will play in getting America back to work,” said Scott Whitaker, AdvaMed president and CEO. “The medtech executives on this task force have decades of experience in getting crucial devices and diagnostics into the hands of those who need them, and the country will be well served by their expertise.”
Curious how medtech's top companies are responding to the COVID-19 pandemic? Get insights into each company's actions by clicking here.
Medical technology company executives on the White House task force include:
Cardinal Health – Mike Kaufmann
McKesson – Brian Tyler
3M – Mike Roman
Abbott Laboratories – Robert Ford
Johnson & Johnson – Alex Gorsky
Thermo Fisher Scientific – Marc Casper
Roche Diagnostics – Matthew Sause
“The inclusion of so many medtech community leaders on this key White House task force speaks to the important role our industry will play in getting America back to work,” said Scott Whitaker, AdvaMed president and CEO. “The medtech executives on this task force have decades of experience in getting crucial devices and diagnostics into the hands of those who need them, and the country will be well served by their expertise.”
Curious how medtech's top companies are responding to the COVID-19 pandemic? Get insights into each company's actions by clicking here.
Medical technology company executives on the White House task force include:
Cardinal Health – Mike Kaufmann
McKesson – Brian Tyler
3M – Mike Roman
Abbott Laboratories – Robert Ford
Johnson & Johnson – Alex Gorsky
Thermo Fisher Scientific – Marc Casper
Roche Diagnostics – Matthew Sause